“Age Related Differences in the Biology of Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation”

Overview of attention for article published in Frontiers in immunology, October 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 41 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 15 publications that cite this research output.

15

The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.

Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development

Article in Current Oncology (March 2024)

Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3+ T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow Grafts

Article in Transplantation and Cellular Therapy (December 2023)

Treatment of steroid-refractory graft versus host disease in children

Article in Frontiers in Transplantation (September 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.